Brian Stephenson, Ph.D., CFA

Brian Stephenson, Ph.D., CFA

Former Chief Financial OfficeratBridgeBio Pharma· In proxies 2021–2025

Pay in FY2024-15% from the year before · BridgeBio Pharma stock -32.0% the same year

Brian Stephenson, Ph.D., CFA was paid $5.7M in FY2024 (Dec), down 15%. BridgeBio Pharma stock fell 32.0% that year.

Pay$100 in the stock at the end of FY20 → $39
Pay is from the Summary Compensation Table of each BridgeBio Pharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. BridgeBio PharmaPublic company · 5 yr
    • Former Chief Financial Officer2021 – Present · 5 yrStock in role +2%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?